ADCs, Oncology Move To Fore In Korean Biopharma Alliances
Plus Pandemic-Related Production Deals
Although there weren’t many large-scale partnerships as in previous years, Korean biopharma firms were involved in a broad range of deals across diverse therapeutic areas in 2020, with ADCs, oncology and domestic alliances emerging as key trends.
